Daily news email for July 28, 2010 | Click here for updated news
SourceSolution News
New reporting features added to the Supplier Relationship Management system. Sign up here for our daily webinar to learn more.
Search over 86,000 clinical trials by phase of development and indication at www.sourcesolution.com
PlanIt client portal software lets you exchange and track documents, manage budgets and assign tasks. 3 day implementation!
|
BioSpace
Generex Biotechnology Corporation Provides Positive Update On Oral-Lyn(TM) Pivotal Phase III Trial
Morphine Blocks Tumor Growth, University of Minnesota Study
One Molecule, Many More Insulin-Producing Cells To Treat Diabetes, Says University of Pittsburgh School of Medicine Team
Allos Therapeutics, Inc.'s Cancer Drug, Folotyn Extends Lung Cancer Survival
EMD Serono, Inc., Merck KGaA Says FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS
|
BioSpace - Breaking News
ArQule, Inc. Announces Initiation by Kyowa Hakko Kirin of Phase 2 Clinical Trial in Asia with ARQ 197 in Gastric Cancer
Pharmasset, Inc. Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-938 in Patients with Chronic Hepatitis C
Limerick BioPharma Inc. Announces Positive Phase 1b Data for LIM-0705 in Preventing Toxicities Associated with the Transplant Drug, Tacrolimus
DiaMedica Inc. Announces Autoimmune Program With Positive Rheumatoid Arthritis Results
EpiCept Corporation Amends Employment Agreement and Completes Severance Agreements with Executive Officers
|
New York Times- Pharmaceuticals
South Africa Redoubles Efforts Against AIDS
A Promising AIDS Preventive
F.D.A. Panel Urges Limits For Avastin
Lifesaving Medications, Through a Back Door
African Studies Give Women Hope in H.I.V. Fight
|
OnBioVC
Reinnervate, Ltd.: Series A $2M
Noxxon Pharma, AG: Series D $40M
Palmaz Scientific, Inc.: Series A $3M
Phreesia, Inc.: Series D $16M
Coskata, Inc.: Series D $23.7M
|
Outsourcing-Pharma
Biomarkers indispensible in cancer drug development, says Quintiles
Data, patients and payers key to New Health success, says Quintiles
Safety and value driving Phase IV growth at CROs; EVP
Potential for trials in Russia "enormous", says ClinStar
US presence is a must for biologics producers, says Recipharm
|
PRWeb - Pharmaceuticals
USAsafety.com: New Gas Cylinder Cabinets Offer Affordable Storage...
Grow Your Business with Health Food Exchange, a Global B2B Marketplace...
Portafab Modular Building Systems Achieves ISO 9001:2008 Certification
Amerivap Systems Uses New Facility to Expand its Focus on Web Based...
Global Health Care Leader Selects Model N Contract Authoring Solution
|
Scientific American
Self-Fulfilling Fakery: Feigning Mental Illness Is a Form of Self-Deception
Spread of Deadly Cryptococcal Disease in U.S. Northwest Linked to Global Warming
How Will the Smart Grid Handle Heat Waves
More Education Delays Dementia Signs--But Not Damage
Climate Change May Mean More Mexican Immigration
|
Xconomy Life Sciences
HemaQuest Raises $4M More, Boosting VC Round to $16M for Sickle Cell, Blood Disorders
BioScale, Mastering Acoustics for Molecular Detection, Gets Nod from Millennium Pharma
Washington Startups Pull In $104.3M in June; Healthcare and Energy/Utilities Sectors Top the List
Oclaro Buys Mintera, Gazelle Gets $12M, Genzyme Buyout Rumors Swirl, & More Boston-Area Deals News
Illumina Acquires Helixis for Up to $105M, To Get Small, Low-Cost Genetic Analysis Tool
|
